Laurent Morin

Learn More
The improvements in semiconductor technologies are gradually enabling extreme-scale systems such as teradevices (i.e., chips composed by 1000 billion of transistors), most likely by 2020. Three major challenges have been identified: programmability, manageable architecture design, and reliability. TERAFLUX is a Future and Emerging Technology (FET)(More)
Thanks to the improvements in semiconductor technologies, extreme-scale systems such as teradevices (i.e., composed by 1000 billion of transistors) will enable systems with 1000+ general purpose cores per chip, probably by 2020. Three major challenges have been identified: programmability, manageable architecture design, and reliability. TERAFLUX is a(More)
Atrial fibrillation (AF) is a common supraventricular arrhythmia that increases in prevalence with increasing age and in the presence of comorbidities such as heart failure (HF). AF increases the risk of a number of serious complications, including stroke and HF. As a result, the rate of hospitalization is high, making AF a costly disease. Treatment(More)
BACKGROUND Mandibular repositioning devices (MRDs) are usually recommended as the first therapy option in patients with mild-to-moderate obstructive sleep apnoea (OSA). However, data on the long-term efficacy of MRDs are limited, not only in OSA patients who are noncompliant with continuous positive airway pressure (CPAP) but also in those with more severe(More)
OBJECTIVE/BACKGROUND In obstructive sleep apnea (OSA), long-term adherence to treatment is crucial. This prospective single-center study investigated factors associated with long-term adherence to mandibular repositioning device (MRD) therapy. PATIENTS/METHODS All OSA patients who had MRD treatment initiated in the previous year were prospectively(More)